Notice ID: 256915d8d0524d639ce846d2feefd189Special Notice
6505--F-18 Pylarify / Piflufolastat - Injectable Radiopharmaceutical Ann Arbor - Nuclear Medicine Brand Name Only
Archived on September 26, 2023. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 12:00 PM UTC−04:00
- Posted
- September 6, 2023
- Notice type
- Special Notice
- NAICS
- 325412: Pharmaceutical Preparation Manufacturing
- Agency
- Department of Veterans Affairs
Notice details
- Office
- 250-NETWORK CONTRACT OFFICE 10 (36C250)
- Last updated
- Dec 6, 2025
Identifiers
- Solicitation number
- 36C25024Q0013
- Notice ID
- 256915d8d0524d639ce846d2feefd189
Description
Description The Department of Veterans Affairs, VHA Regional Procurement Office Central, Network Contracting Office 10, located at 3140 Governor s Place Blvd., Suite 210, Kettering, OH 45409 intends to award a single-award, firm-fixed-priced FSS contract from 10/01/2023 until 09/30/2024 to Progenics Pharmaceuticals, Inc., a Lantheus company. A determination by the Government not to compete the proposed acquisition will be based upon responses of this notice, it is solely within the discretion of the Government. Inquiries shall be emailed to LouAnn.Gilliland@va.gov. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government in future procurements. The Progenics Pharmaceuticals, Inc. s address is at 331 Treble Cove Road, North Billerica, MA, 01862, United States. This award will be for the Nuclear Medicine Clinic at the Ann Arbor VAMC, Ann Arbor, MI 48105. The acquisition is conducted under authority of the Multiple Award Schedule Program; FAR Subpart 8.405-6(b) Items Peculiar to one Manufacturer. The primary statutory authorities for the MAS program are 41 U.S.C. 152(3), Competitive Procedures, and 40 U.S.C. 501, Service for Executive Agencies. It is the Government s belief the proposed candidate is the sole manufacturer capable of meeting the requirement. The associated North America Classification Systems (NAICS) Code is 325412 and the Small Business Size Standard is 1,300 employees. It is the Government s belief the proposed candidate is the only source with the required capabilities to successfully meet the requirement for PYLARIFY® (piflufolastat F 18) Injection, which is a radioactive diagnostic agent for men with prostate cancer. This is an FDA approved, proprietary item available only through the sole manufacturer and authorized supplier of PYLARIFY. This notice satisfies the requirement at FAR 5.201(b)(1), to publicize the proposed contract action. This notice of intent is not a request for competitive proposals. No solicitation documents are available at this time. Interested parties may give written notice to LouAnn.Gilliland@va.gov by 12:00pm e.s.t. on September 11, 2023. No telephone requests will be accepted.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
36C25024Q0013- Special NoticeCurrentSep 6, 2023
6505--F-18 Pylarify / Piflufolastat - Injectable Radiopharmaceutical Ann Arbor - Nuclear Medicine Brand Name Only
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
36C25024Q0013
Archive Date
Sep 26, 2023
Office Address
DAYTON, OH, 45428